Plasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Induction

Simple item page
dc.contributor.authorIdowu, A.O.
dc.contributor.authorBhattacharyya, S.
dc.contributor.authorGradus, S.
dc.contributor.authorOyibo, W.A.
dc.contributor.authorGeorge, Z.
dc.contributor.authorBlack, C.
dc.contributor.authorIgietseme, J.
dc.contributor.authorAzenabor, A.A.
dc.date.accessioned2022-01-04T15:31:21Z
dc.date.available2022-01-04T15:31:21Z
dc.date.issued2018-09-09
dc.descriptionScholarly articlesen_US
dc.description.abstractThe artemisinin-based combined therapy (ACT) post-treatment illness in Plasmodium falciparum-endemic areas is characterized by vague malaria-like symptoms. The roles of treatment modality, persistence of parasites and host proinflammatory response in disease course are unknown. We investigated the hypothesis that ACT post-treatment syndrome is driven by parasite genetic polymorphisms and proinflammatory response to persisting mutant parasites. Patients were categorized as treated, untreated, and malaria-negative. Malaria-positive samples were analyzed for Pfcrt, Pfmdr1, K13 kelch gene polymorphisms, while all samples were evaluated for cytokines (TNF-α, IL-12p70, IL-10, TGF-β, IFN-γ) and corticosteroids (cortisol and dexamethasone) levels. The treated patients exhibited higher levels of parasitemia, TNF-α, and cortisol, increased incidence of parasite genetic mutations, and a greater number of mutant alleles per patient. In addition, corticosteroid levels declined with increasing number of mutant alleles. TGF-β levels were negatively correlated with parasitemia, while IL-10 and TGF-β were negatively correlated with increasing number of mutant alleles. However, IL-12 displayed a slight positive correlation and TNF-α exhibited moderate positive correlation with increasing number of mutant alleles. Since post-treatment management ultimately results in patient recovery, the high parasite gene polymorphism may act in concert with induced cortisol and TNF-α to account for ACT post-treatment syndrome.en_US
dc.identifier.citationIdowu AO, Bhattacharyya S, Gradus S, Oyibo W, George Z, Black C, Igietseme J, Azenabor AA. Plasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Induction. Int J Med Sci 2018; 15(13):1449-1457. doi:10.7150/ijms.27350.en_US
dc.identifier.issn1449-1907
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/9939
dc.language.isoenen_US
dc.publisherInternational Journal of Medical Sciencesen_US
dc.subjectProinflamationen_US
dc.subjectCortisolen_US
dc.subjectCorticosteroidsen_US
dc.subjectGeneen_US
dc.subjectResearch Subject Categories::MEDICINEen_US
dc.titlePlasmodium falciparum Treated with Artemisinin-based Combined Therapy Exhibits Enhanced Mutation, Heightened Cortisol and TNF-α Inductionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Plasmodium falciparum Treated with Artemisinin-based.pdf
Size:
821.37 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Pharmaceutics and Pharmaceutical Technology- Scholarly Publications